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ORIgINAL ARtICLE
ABSTRACT
INTRODUCTION: From January 2013, we changed the 
surgical strategy in our department and ceased to perform 
the through-knee amputation (TKA). The primary aim of this 
study was to investigate re-amputation rates ≤ 90 days after 
non-traumatic major lower-extremity amputations 
performed before and after this change of practice. 
Furthermore, we reported mortality before and after the 
change of practice.
METHODS: All non-traumatic major lower-extremity 
amputations performed in a single centre in two study 
periods (before and after the change of practice); 2009-2012 
(cohort A) and 2014-2015 (cohort B) were included. Re-
amputations and all-cause mortality ≤ 90 days after the 
index amputations were analysed. 
RESULTS: Cohort A: Included 180 amputations with 27 
below-knee amputations (BKA), 68 TKAs and 85 above-knee 
amputations (AKA). 86.7% of patients were American Society 
of Anesthesiologists (ASA) score 3-5. The re-amputation rate 
≤ 90 days was 29.6% (95% confidence interval (CI): 12.7-
47.3%) after BKA, 33.8% (95% CI: 22.7-45.3%) after TKA, 9.4% 
(95% CI: 2.9-15.1%) after AKA and 21.6% (95% CI: 15.6-27.6%) 
overall. The overall mortality ≤ 90 days was 35.2% (95% CI: 
26.2-44.2%). Cohort B: Included 116 amputations with 21 BKA 
and 95 AKA. 92.7% of patients were ASA score 3-5. The re-
amputation rate ≤ 90 days was 19.1% (95% CI: 7.7-40.0%) 
after BKA, 2.1% (95% CI: 0.6-7.4%) after AKA and 5.2% (95% CI: 
2.4-10.8%) overall. The overall mortality ≤ 90 days was 32.8% 
(95% CI: 26.2-44.2%). 
CONCLUSIONS: The overall re-amputation rate ≤ 90 days 
following major lower-extremity amputation decreased 
significantly from 22% to 5% after cessation of the TKA 
procedures, but mortality remained unchanged.
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Re-amputations and mortality  
after below-knee, through-knee  
and above-knee amputations
Major amputation of the lower extremity has been re-
ported to be associated with high levels of re-amputa-
tion and high mortality rates [1-5]. 
The few studies addressing re-amputation rates of 
major lower-limb amputations report rates of conver-
sion from below-knee amputation (BKA) to above-knee 
amputation (AKA) at 9-28% [2, 4, 6]. An alternative to 
BKA and AKA is a through-knee amputation (TKA). The 
TKA procedure is performed more rarely, and limited 
data exist on the outcome after this procedure. A litera-
ture review reported healing rates between 60% and 
90% after TKA procedures [7].    
BKA and AKA have been associated with 30-day 
mortality rates of 5-10% and 10-17%, respectively [2, 
8, 9].  A Danish single-centre study reported a mortal-
ity of more than 30% within 30 days and 50% within 
one year post-operatively in a cohort of both BKA and 
AKA procedures [3].
As from January 2013, we changed the surgical 
strategy in our department ceasing to perform the TKA 
procedure due to suspicion that more re-amputations 
may be associated with this procedure. Hence, the aim 
of this study was primarily to investigate re-amputation 
rates ≤ 90 days after non-traumatic major lower-ex-
tremity amputations performed before and after this 
change of practice; secondarily, to report the all-cause 
post-operative mortality before and after the change of 
practice.
METHODS
This was a retrospective comparative study investi-
gating the outcome after non-traumatic major lower- 
extremity amputations performed in two study periods; 
before and after change of surgical practice, respect-
ively. Before 2013, BKA, TKA and AKA procedures were 
performed in our department according to local guide-
lines and on indication. The BKA procedure was to be 
performed in patients who were leg-prosthesis candi-
dates and who had sufficient skin perfusion (> 40 
mmHg and > 55 mmHg in diabetics) below the knee, 
whereas TKA was to be performed in patients who were 
not prosthesis candidates, but with sufficient skin per-
fusion below the knee. The AKA procedure was to be 
performed if BKA and TKA were not possible, e.g., due 
to insufficient skin perfusion or wound problems 
around the knee.
After 2013, local guidelines were changed, and the 
TKA procedure was no longer performed. The indica-
tion for BKA remained the same, but the AKA proced-
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ure was to be performed in all patients with no poten-
tial for a leg prosthesis.
The local guidelines for the surgical technique did 
not change either before or after the change of practice. 
Anterior and posterior skin flaps were used for the AKA 
[10, 11]. A long anterior skin flap and a shorter pos-
terior flap were used for the TKA. For all procedures, 
skin closure was performed with non-absorbable nylon 
sutures. 
To evaluate the effect of the change of surgical 
treatment protocol, we investigated a consecutive co-
hort (cohort A) of non-traumatic major lower-extrem-
ity amputation patients before the change of practice 
and another cohort after the change (cohort B). In or-
der to ensure that the new guidelines were followed, 
the second study period (cohort B) started one year  
after the change of practice.       
Using a computerised surgery booking system 
(ORBIT), a transcript of all major lower-limb amputa-
tions performed in the two study periods was collected; 
from 1 January 2009 to 31 December 2012 (cohort A) 
and from 1 January 2014 to 31 December2015 (cohort 
B). Surgery was performed at Bispebjerg Hospital, 
Denmark, situated in an urban area accommodating 
410,000 people. Consultant orthopaedic surgeons or 
orthopaedic trainees performed the amputation pro-
ced ures. Re-amputations (all limb-shortening proced-
ures) and mortality within 90 days following the index 
amputation were registered through examination of 
medical records. Indications for re-amputations were 
wound rupture, wound necrosis and infection when 
soft tissue debridement was considered insufficient  
following clinical assessment. All re-amputations per-
formed in any hospitals within the Capital Region were 
registered based on evaluation of patient records.  
All-cause mortality was determined and confirmed 
through the National Central Office of Civil Regis tra-
tion (CPR), which is based on the unique personal so-
cial security number given to all residents of Denmark. 
Mortality was analysed as the number of deaths in the 
total number of patients, also in case of bilateral ampu-
tation. 
 Furthermore, basic demographics such as smoking 
habits, alcohol consumption, skin perfusion test results 
and whether patients came from a nursing home (resi-
dential accommodation providing 24-hour nursing 
care) were registered based on evaluation of patient re-
cords. An American Society of Anesthesiologists (ASA) 
score at the time of surgery was collected from the 
Danish Anaesthesia Database. 
Patients with a BKA index procedure and a subse-
quent AKA were only registered in the BKA group. 
Statistical analysis
Means with ranges were reported for normally distrib-
uted data and proportions were expressed as per-
centages with 95% confidence intervals (CI). Crude 
comparisons of proportions were done using the chi-
squared test. Any p-value of 0.05 or less was considered 
statistically significant. Statistical analyses were done 
using SPSS, version 20.
Ethics
As this study was retrospective and non-interventional, 
no ethical approval was required. Permission was ac-
quired from the Danish Data Protection Agency, auth-
orisation number 2012-58-0004.
Trail registration: not relevant.
RESULTS
Cohort A
From 1 January 2009 to 31 December 2012 (Table 1 
and Table 2). A total of 180 major lower-extremity am-
putations were performed in 167 patients. A total of 13 
patients were bilaterally amputated. Skin perfusion 
tests were performed before 21 of the 27 BKA proced-
ures (78%), 51 of the 68 TKA procedures (75%) and 39 
of the 85 AKA procedures (46%). 
The 90-day re-amputation rate was 30% (95% CI: 
12.7-47.3%) after BKA, 34% (95% CI: 22.7-45.3%)  
after TKA, 9% (95% CI: 2.9-15.1%) after AKA and 22% 
(95% CI: 15.6-27.6%) overall. Causes of re-amputa-
tions after AKA were infection in four cases, wound ne-
crosis in two cases and wound rupture in two cases. 
After TKA, the re-amputations were caused by infection 
in nine cases, wound necrosis in nine cases and wound 
rupture in five cases. After BKA, re-amputations were 
caused by infection in three cases and wound necrosis 
in six cases. The overall all-cause mortality within 90 
days post-operatively was 35% (95% CI: 26.2-44.2%); 
31% (95% CI: 9.1-61.4%) (four out of 13 patients) 
who underwent bilateral amputation died within 90 
days post-operatively. 
Cohort B
From 1 January 2014 to 31 December 2015 (Table 3 
and Table 4). A total of 116 major lower-extremity am-
putations were performed in 108 patients. Eight pa-
tients were bilaterally amputated. Skin perfusion tests 
were performed before 16 of 21 the BKA procedures 
(75%) and 24 of the 95 AKA procedures (25%). 
The 90-day re-amputation rate was 19% (95% CI: 
7.7-40.0%) after BKA, 2% (95% CI: 0.6-7.4%) after 
AKA and 5% (95% CI: 2.4-10.8%) overall. Causes of re-
amputations after BKA were infection in two cases and 
wound rupture in two cases. The two re-amputations 
after AKA were also caused by infection (n = 1) and 
wound rupture (n = 1). The overall all-cause mortality 
within 90 days post-operatively was 33% (95% CI: 
3DANISH MEDICAL JOURNAL
Dan Med J 65/12  December 2018 
26.2-44.2%). Four out of eight patients who underwent 
bilateral femoral amputation died within 90 days post-
operatively. The overall re-amputation rate was signifi-
cantly reduced from 22% (95% CI: 15.6-27.6%) in co-
hort A to 5% (95% CI: 2.4-10.8%) in cohort B after the 
change of practice (p = 0.002), but the overall 90-day 
mortality rate remained at the same level before and  
after the change of practice (p = 0.8). 
DISCUSSION
In this retrospective single-centre study, we compared 
re-amputation rates and mortality before and after a 
change of major lower-extremity amputation practice 
involving discontinuation of the TKA procedure. The 
main finding was a significant reduction in the overall 
90-day re-amputation rate from 22% to 5% after the 
change of practice. The re-amputation rate of 34% after 
the TKA procedure was high, and it was the main cause 
of the higher overall re-amputation rate after major 
lower-extremity amputations before the change of 
practice. The higher re-amputation rate after TKA in 
our study may be due to multiple factors. The pro ced-
ure itself with limited soft tissue coverage over the 
bone may provide part of the explanation, and atrau-
matic surgical technique may be even more important 
when handling the skin in this procedure than in the 
other amputations. Hence, the TKA procedure may 
place greater demands on surgical experience. Poor 
skin perfusion at the level of the amputation is also im-
portant.  In our study, the skin perfusion test was > 40 
mmHg in 18 of the 19 TKA patients who were subse-
quently re-amputated. However, another 15 patients 
were re-amputated but had no skin perfusion test per-
formed, making interpretation of the result difficult. In 
future prospective studies, skin perfusion tests should 
be performed prior to all amputation procedures to fa-
cilitate conclusions on the importance of skin perfusion 
in relation to healing rates. Finally, patient comorbidity 
may play an important role, and in our study the TKA 
patients had the highest comorbidity burden (95% ASA 
score 3-5), which may also increase risk of complica-
tions and re-amputations. 
The cessation of the TKA procedure may only ex-
plain part of the significant drop in the re-amputation 
rate. We found a drop in the re-amputation rate in both 
the BKA (30% to 19%) and the AKA (9% to 2%) group 
from cohort A to cohort B, which also contributed to 
the decrease in the overall re-amputation rate. The  
demographics also changed between the two cohorts. 
We found a lower rate of smokers, alcohol abusers, dia-
TABLE 1
BKA 
(N = 27)
tKA
(N = 68)
AKA
(N = 85)
Overall
(N = 180)
Age, yrs, mean (range) 71 (44-97) 75.4 (44-97) 76.1 (42-95) 75.1 (42-97)
Male, % 66.7 58.8 49.4 57.4
Previous or current smokers, n (%) 24 (89) 49 (72) 61 (72) 134 (74)
Alcohol consumers above recommendation, n (%)a 10 (37) 36 (53) 27 (32) 73 (41)
Medically treated diabetes, n (%) 19 (70) 32 (47) 51 (60) 102 (57)
Heart failure, n (%) 6 (22) 30 (44) 31 (37) 67 (37)
Chronic obstructive pulmonary disease, n (%) 4 (15) 19 (28) 19 (22) 42 (23)
From nursing home, n (%)b 9 (33) 28 (41) 17 (20) 54 (30)
ASA score, n (%)
1-2   6 (22)   4 (6) 14 (16)   24 (13)
3-5 21 (78) 64 (94) 71 (84) 156 (87)
Re-amputation rate, ≤ 90 days, % (95% CI) 30 (12.7-47.3) 34 (22.7-45.3) 9 (2.9-15.1) 22 (15.6-27.6)
Mortality rate, ≤ 90 days, % (95% CI) 0 38 (26.5-49.5) 44 (33.3-54.4) 35 (28.4-42.4)
AKA = above-knee amputation; ASA = American Society of Anesthesiologists; BKA = below-knee amputation; CI = confidence interval; TKA = through-knee  
amputation.
a) The Danish Health Authority recommends a weekly consumption < 14/21 U alcohol for women/men, respectively.
b) Residential accommodation providing 24-h nursing care.
Cohort A (January 
2009-December 2012): 
patient characteristics 
and outcomes after be-
low-knee amputation, 
through-knee amputa-
tion and above-knee 
amputation.
TABLE 2
Skin perfusion test data from below-knee amputation, through-
knee amputation and above-knee amputation patients in cohort A 
(January 2009-December 2012). The values are n.
Skin perfusion,  
mmHg
BKA 
(N = 21)
tKA
(N = 51)
AKA
(N = 39)
< 40   2   1 24
40-70 14 45 13
> 70   5   5   2
AKA = above-knee amputation; BKA = below-knee amputation;  
TKA = through-knee amputation.
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betics and heart failure patients, which is expected to 
influence the lower re-amputation rate. In addition, 
more patients (38% compared with 30%) came from a 
nursing home. We speculate that patients from nursing 
homes may receive better overall treatment and wound 
treatment than patients returning to their own home. 
Finally, the change of practice at our institution may by 
itself have brought an enhanced focus on the specific 
patient group yielding an improved overall treatment. 
Limited data exists on re-amputation rates after 
TKA, but low healing rates of about 60% after TKA 
have been reported previously [7]. Lim et al reported 
re-amputation rates of 17.6% after BKA, 20% after TKA 
and 0% after AKA [5], while Kristensen et al reported 
an overall re-amputation rate of 40% in a cohort of 71 
BKA and 58 AKA procedures [12]. Due to the lack of 
conformity between the few previously performed 
studies mentioned above and our study, direct compar-
ison of re-amputation rates is difficult, and this con-
firms the need for more outcome data following these 
procedures.
The 90-day mortality rates of 33-35% overall re-
mained unchanged in our institution in the two exam-
ined cohorts, representing an important challenge. Our 
results may indicate that mortality is not linked to the 
frequency of re-amputation, and that patients with a 
TKA or higher are frail and have a high mortality rate 
that are not associated with ASA scores and confound-
ing factors. A recent Danish study reported a reduction 
in mortality after implementation of an enhanced  
multidisciplinary programme with increased attention 
to amputation patients. The patients’ 30-day and one-
year overall mortality rates dropped from 35% and 
59% to 16% and 37%, respectively [12]. A remarkable 
discrepancy was found when comparing the BKA/AKA 
ratio of 21/95 in our cohort B with the 71/58 ratio re-
ported by Kristensen et al [12]. The known frailty in 
AKA patients with poor rehabilitation potential [13] 
may therefore be a part of the explanation for the high 
mortality rate found in our cohort. Furthermore, the 
bulk of amputation patients in our cohort had an ASA 
score of 3-5 (87% in cohort A and 93% in cohort B), 
while Kristensen et al reported 69% with ASA score 
3-5. Finally, we chose to include bilateral cases and 
found that mortality was even higher in these cases 
(50% in cohort B), which could add to the higher mor-
tality rate compared with other studies in which bilat-
eral cases were excluded. Thus, the patients analysed 
in our study seem to have been more at risk than the 
patients from the recently published Danish single- 
centre study [12].
A future and already initiated strategy to lower 
mortality is to assemble major lower-extremity ampu-
tation patients in a specialised unit with uniform treat-
ment protocols. Hence, early mobilisation and intro-
duction of guidelines for oxygen administration, fluid 
resuscitation and transfusion limits that are specific to 
amputation patients have been introduced [12]. 
The retrospective nature of this study is an obvious 
limitation, but to our knowledge no prospective studies 
comparing major lower-extremity amputation proced-
ures exist. Another limitation is that we report all-cause 
mortality and not only surgically related mortality. 
Furthermore, we only had data available on re-amputa-
tions performed within the Capital Region and hence 
we may underestimate re-amputation rates slightly as  
a limited number of re-amputations might have been 
performed outside the Capital Region. A strength of our 
study is the large total cohort of major lower-extremity 
amputations including the largest amount of TKA pro-
cedures reported on so far. 
TABLE 4
Skin perfusion test data from below-knee amputation and above-
knee amputation patients in cohort B (January 2014-December 
2015). The values are n.
Skin perfusion, mmHg
BKA 
(N = 16)
AKA
(N = 24)
< 40   0 8
40-70   6 8
> 70 10 8
AKA = above-knee amputation; BKA = below-knee amputation.
TABLE 3
Cohort B (January 2014-December 2015): patient characteristics and outcomes after  
below-knee amputation and above-knee amputation.
BKA 
(N = 21)
AKA
(N = 95)
Overall
(N = 116)
Age, yrs, mean (range) 67 (46-85) 78 (40-99)   76 (40-99)
Male, % 86 59   64
Previous or current smokers, n (%) 11 (52) 65 (68)   76 (66)
Alcohol consumers above recommendation, n (%)a   5 (24) 25 (26)   30 (26)
Medically treated diabetes, n (%) 15 (71) 29 (31)   44 (38)
Heart failure, n (%)   2 (10) 28 (30)   30 (26)
Chronic obstructive pulmonary disease, n (%)   2 (10) 24 (25)   26 (22)
From nursing home, n (%)b   1 (5) 43 (45)   44 (38)
ASA score, n (%)c
1-2   3 (15)   5 (6)     8 (7)
3-5 17 (85) 85 (94) 102 (93)
Re-amputation rate, ≤ 90 days, % (95% CI) 19 (7.7-40.0)   2 (0.6-7.4)     5 (2.4-10.8)
Mortality rate, ≤ 90 days, % (95% CI)   0 40 (33.5-52.8) 33% (26.2-44.2)
AKA = above-knee amputation; ASA = American Society of Anesthesiologists; BKA = below-knee amputation; 
CI = confidence interval.
a) The Danish Health Authority recommends weekly consumption < 14/21 U alcohol for women/men,  
respectively.
b) Residential accommodation providing 24-h nursing care.
c) 6 missing ASA scores.
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CONCLUSIONS
In conclusion, we found a significant decrease in the 
overall 90-day re-amputation rate following major 
lower-extremity amputation from 22% to 5% after a 
change of practice with discontinuation of the TKA  
procedures, indicating that the TKA procedure may be 
associated with higher re-amputation rates. However, 
future comparative prospective studies with fewer con-
founding factors are needed to validate our results. The 
overall all-cause 90-day mortality rate was 35% before 
and 33% after the change of practice and this remains a 
challenge in this group of very frail patients. 
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